379 related articles for article (PubMed ID: 25807073)
1. 5% Minoxidil: treatment for female pattern hair loss.
Gupta AK; Foley KA
Skin Therapy Lett; 2014; 19(6):5-7. PubMed ID: 25807073
[TBL] [Abstract][Full Text] [Related]
2. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
4. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss.
Bergfeld W; Washenik K; Callender V; Zhang P; Quiza C; Doshi U; Blume-Peytavi U
J Drugs Dermatol; 2016 Jul; 15(7):874-81. PubMed ID: 27391639
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.
Blume-Peytavi U; Shapiro J; Messenger AG; Hordinsky MK; Zhang P; Quiza C; Doshi U; Olsen EA
J Drugs Dermatol; 2016 Jul; 15(7):883-9. PubMed ID: 27391640
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
7. Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
McCoy J; Goren A; Kovacevic M; Shapiro J
J Biol Regul Homeost Agents; 2016; 30(4):1153-1155. PubMed ID: 28078868
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia.
McMichael A; Pham H; von Grote E; Meckfessel MH
J Drugs Dermatol; 2016 Apr; 15(4):398-404. PubMed ID: 27050694
[TBL] [Abstract][Full Text] [Related]
10. Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: A randomized controlled study.
Esmat SM; Hegazy RA; Gawdat HI; Abdel Hay RM; Allam RS; El Naggar R; Moneib H
Lasers Surg Med; 2017 Nov; 49(9):835-843. PubMed ID: 28489273
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
12. Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.
Pumthong G; Asawanonda P; Varothai S; Jariyasethavong V; Triwongwaranat D; Suthipinittharm P; Ingkaninan K; Leelapornpisit P; Waranuch N
J Dermatolog Treat; 2012 Oct; 23(5):385-92. PubMed ID: 21756154
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
Olsen EA; DeLong ER; Weiner MS
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):688-95. PubMed ID: 3549803
[TBL] [Abstract][Full Text] [Related]
14. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
15. [Effect of minoxidil on hair growth in androgenic alopecia in women].
Brzezińska-Wcisło L
Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
[TBL] [Abstract][Full Text] [Related]
16. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
17. Topical minoxidil therapy for hair regrowth.
Rumsfield JA; West DP; Fiedler-Weiss VC
Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
[TBL] [Abstract][Full Text] [Related]
18. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review.
van Zuuren EJ; Fedorowicz Z; Carter B
Br J Dermatol; 2012 Nov; 167(5):995-1010. PubMed ID: 23039053
[TBL] [Abstract][Full Text] [Related]
20. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
Sinclair RD
Int J Dermatol; 2018 Jan; 57(1):104-109. PubMed ID: 29231239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
